Literature DB >> 33585162

Target validity: Bringing treatment of external validity in line with internal validity.

Catherine R Lesko1, Benjamin Ackerman2, Michael Webster-Clark3, Jessie K Edwards3.   

Abstract

PURPOSE OF REVIEW: "Target bias" is the difference between an estimate of association from a study sample and the causal effect in the target population of interest. It is the sum of internal and external bias. Given the extensive literature on internal validity, here, we review threats and methods to improve external validity. RECENT
FINDINGS: External bias may arise when the distribution of modifiers of the effect of treatment differs between the study sample and the target population. Methods including those based on modeling the outcome, modeling sample membership, and doubly robust methods are available, assuming data on the target population is available.
SUMMARY: The relevance of information for making policy decisions is dependent on both the actions that were studied and the sample in which they were evaluated. Combining methods for addressing internal and external validity can improve the policy relevance of study results.

Entities:  

Keywords:  External Validity; Generalizability; Internal Validity; Randomized Trials; Target Population; Transportability

Year:  2020        PMID: 33585162      PMCID: PMC7879946          DOI: 10.1007/s40471-020-00239-0

Source DB:  PubMed          Journal:  Curr Epidemiol Rep


  58 in total

1.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Authors:  Sean R Tunis; Daniel B Stryer; Carolyn M Clancy
Journal:  JAMA       Date:  2003-09-24       Impact factor: 56.272

3.  How to assess the external validity of therapeutic trials: a conceptual approach.

Authors:  O M Dekkers; E von Elm; A Algra; J A Romijn; J P Vandenbroucke
Journal:  Int J Epidemiol       Date:  2009-04-17       Impact factor: 7.196

4.  Representativeness is not helpful in studying heterogeneity of effects across subgroups.

Authors:  Kj Rothman; Ee Hatch; Jej Gallacher
Journal:  Int J Epidemiol       Date:  2014-01-06       Impact factor: 7.196

5.  Commentary: External validity of results of randomized trials: disentangling a complex concept.

Authors:  Peter M Rothwell
Journal:  Int J Epidemiol       Date:  2009-09-23       Impact factor: 7.196

6.  Generalisability of an online randomised controlled trial: an empirical analysis.

Authors:  Cheng Wang; Katie R Mollan; Michael G Hudgens; Joseph D Tucker; Heping Zheng; Weiming Tang; Li Ling
Journal:  J Epidemiol Community Health       Date:  2017-11-28       Impact factor: 3.710

7.  Causal diagrams for epidemiologic research.

Authors:  S Greenland; J Pearl; J M Robins
Journal:  Epidemiology       Date:  1999-01       Impact factor: 4.822

8.  Extending inferences from a randomized trial to a target population.

Authors:  Issa J Dahabreh; Miguel A Hernán
Journal:  Eur J Epidemiol       Date:  2019-06-19       Impact factor: 8.082

9.  Generalizability of clinical trial results for generalized anxiety disorder to community samples.

Authors:  Nicolas Hoertel; Yann Le Strat; Carlos Blanco; Pierre Lavaud; Caroline Dubertret
Journal:  Depress Anxiety       Date:  2012-04-11       Impact factor: 6.505

10.  The use of propensity scores and observational data to estimate randomized controlled trial generalizability bias.

Authors:  Taylor R Pressler; Eloise E Kaizar
Journal:  Stat Med       Date:  2013-04-01       Impact factor: 2.373

View more
  3 in total

1.  The value of combining individual and small area sociodemographic data for assessing and handling selective participation in cohort studies: Evidence from the Swedish CardioPulmonary bioImage Study.

Authors:  Carl Bonander; Anton Nilsson; Jonas Björk; Anders Blomberg; Gunnar Engström; Tomas Jernberg; Johan Sundström; Carl Johan Östgren; Göran Bergström; Ulf Strömberg
Journal:  PLoS One       Date:  2022-03-08       Impact factor: 3.240

2.  Cardiotoxicity among socioeconomically marginalized breast cancer patients.

Authors:  Yan Lu; Aaron W Gehr; Ifedioranma Anikpo; Rachel J Meadows; Kevin J Craten; Kalyani Narra; Anuradha Lingam; Sandeep Kamath; Bhavna Tanna; Bassam Ghabach; Rohit P Ojha
Journal:  Breast Cancer Res Treat       Date:  2022-08-15       Impact factor: 4.624

3.  Applicability of evidence from randomized controlled trials and systematic reviews to clinical practice: A conceptual review.

Authors:  Antti Malmivaara
Journal:  J Rehabil Med       Date:  2021-05-11       Impact factor: 2.912

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.